BSAC Spring Conference & AGM

Effective Antimicrobial Management: The What, Why & How

16-17 May 2024

QEII Conference Centre London & online

Karen Gallant

CARB-X Deputy Executive, Director, School of Law, Boston University

Karen Gallant is an internationally experienced pharma R&D and business development executive. During her time in business development at AstraZeneca, she was integral to the building of a rich pipeline of products for treating serious bacterial infections through partnerships, in-licensing and M&A. Prior to joining AZ, she spent several years leading global project teams to deliver innovative medicines across a number of therapeutic areas at Novartis. She serves as a mentor to start-ups through the MassConnect program. She has a PhD in Pharmacology with a specialty in Toxicology.

Top